| Literature DB >> 31896637 |
Nikolay V Volozhantsev1, Angelina A Kislichkina1, Tatiana N Mukhina2, Nadezhda K Fursova2.
Abstract
Klebsiella pneumoniae of capsular type K1 is the most common causative agent of both health care-associated and community-acquired infections. Here, we report the draft genome sequences of 10 K1-type K. pneumoniae strains isolated from patients in an infectious disease hospital and neurosurgical intensive care unit in Russia.Entities:
Year: 2020 PMID: 31896637 PMCID: PMC6940289 DOI: 10.1128/MRA.01250-19
Source DB: PubMed Journal: Microbiol Resour Announc ISSN: 2576-098X
Strain-identifying information and basic statistics on assemblies and annotations
| Strain name | Raw data SRA accession no. | GenBank accession no. | No. of reads | No. of contigs | Genome size (bp) | Total no. of genes | GC content (%) | Genome coverage (×) | Plasmid replicon type(s) | Drug resistance phenotype and predicted resistance gene(s) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLA | AMI | FQN | FOS | PHE | SUL | TRI | TET | MLS | |||||||||||
| KPS73 | 807,366 | 220,354 | 74 | 5,558,879 | 5,451 | 57.2 | 17 | IncHI1B | |||||||||||
| KPB1802 | 729,262 | 157,398 | 74 | 5,620,879 | 5,519 | 57.0 | 25 | IncHI1B | |||||||||||
| KPi1683 | 751,372 | 180,119 | 78 | 5,580,912 | 5,452 | 57.2 | 35 | IncHI1B | |||||||||||
| KPi3695 | 592,094 | 154,881 | 77 | 5,573,189 | 5,453 | 57.1 | 27 | IncHI1B | |||||||||||
| KPB1493 | 501,624 | 56,694 | 300 | 5,521,123 | 5,669 | 57.0 | 22 | IncHI1B, IncFII(K) | |||||||||||
| KPB3188 | 717,240 | 105,254 | 202 | 5,614,863 | 5,675 | 57.0 | 31 | IncHI1B, IncFII(K), IncL/M | |||||||||||
| KPB1103 | 660,384 | 97,397 | 151 | 5,594,258 | 5,644 | 57.2 | 29 | IncHI1B, IncFII(K), IncL/M | |||||||||||
| KPB475 | 980,374 | 151,126 | 143 | 5,661,349 | 5,714 | 56.9 | 42 | IncHI1B, IncFII(K), IncL/M | |||||||||||
| KPB470 | 762,324 | 86,243 | 223 | 5,490,022 | 5,582 | 57.2 | 31 | IncHI1B, IncFII(K), IncL/M | |||||||||||
| KPB463-13 | 688,138 | 99,224 | 245 | 5,811,379 | 5,966 | 56.9 | 29 | IncHI1B, IncFII(K), IncL/M, Col440I, IncFIA(HI1) | |||||||||||
Additional information on strain characterization is provided in a previous publication (7).
BLA, beta-lactams; AMI, aminoglycoside; FQN, fluoroquinolone; FOS, fosfomycin; PHE, phenicol; SUL, sulphonamide; TRI, trimethoprim; TET, tetracycline; MLS, macrolide, lincosamide, and streptogramin B. Resistance phenotype was determined using a Vitek 2 Compact instrument (bioMérieux, France). ResFinder v.2.1 (14) was used to determine the presence of resistance genes.